Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Quality Improvement Goals for Acute Kidney Injury.

Kashani K, Rosner MH, Haase M, Lewington AJP, O'Donoghue DJ, Wilson FP, Nadim MK, Silver SA, Zarbock A, Ostermann M, Mehta RL, Kane-Gill SL, Ding X, Pickkers P, Bihorac A, Siew ED, Barreto EF, Macedo E, Kellum JA, Palevsky PM, Tolwani AJ, Ronco C, Juncos LA, Rewa OG, Bagshaw SM, Mottes TA, Koyner JL, Liu KD, Forni LG, Heung M, Wu VC.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):941-953. doi: 10.2215/CJN.01250119. Epub 2019 May 17.

PMID:
31101671
2.

A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.

Jang SM, Gharibian KN, Lewis SJ, Fissell WH, Tolwani AJ, Mueller BA.

J Clin Pharmacol. 2018 Oct;58(10):1254-1265. doi: 10.1002/jcph.1137. Epub 2018 May 10.

PMID:
29746711
3.

Timing of Renal Replacement Therapy for Acute Kidney Injury.

Karakala N, Tolwani AJ.

J Intensive Care Med. 2019 Feb;34(2):94-103. doi: 10.1177/0885066618774257. Epub 2018 May 8. Review.

PMID:
29739260
4.

Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.

Bagshaw SM, Darmon M, Ostermann M, Finkelstein FO, Wald R, Tolwani AJ, Goldstein SL, Gattas DJ, Uchino S, Hoste EA, Gaudry S.

Intensive Care Med. 2017 Jun;43(6):841-854. doi: 10.1007/s00134-017-4762-8. Epub 2017 Mar 13. Review.

PMID:
28289816
5.

Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.

Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, Fissell WH.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1377-83. doi: 10.2215/CJN.10260915. Epub 2016 May 19.

6.

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.

Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group.

PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.

7.

A Prospective International Multicenter Study of AKI in the Intensive Care Unit.

Bouchard J, Acharya A, Cerda J, Maccariello ER, Madarasu RC, Tolwani AJ, Liang X, Fu P, Liu ZH, Mehta RL.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1324-31. doi: 10.2215/CJN.04360514. Epub 2015 Jul 20.

8.

Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study.

Bouchard J, Malhotra R, Shah S, Kao YT, Vaida F, Gupta A, Berg DT, Grinnell BW, Stofan B, Tolwani AJ, Mehta RL.

PLoS One. 2015 Mar 19;10(3):e0120770. doi: 10.1371/journal.pone.0120770. eCollection 2015.

9.

Assessing continuous renal replacement therapy as a rescue strategy in cardiorenal syndrome 1.

Prins KW, Wille KM, Tallaj JA, Tolwani AJ.

Clin Kidney J. 2015 Feb;8(1):87-92. doi: 10.1093/ckj/sfu123. Epub 2014 Nov 17.

10.

A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.

Ong SC, Wille KM, Speer R, Tolwani AJ.

Int J Artif Organs. 2014 Jun;37(6):499-502. doi: 10.5301/ijao.5000323. Epub 2014 Apr 15.

PMID:
24811309
11.

A patient with AKI after cardiac surgery.

Tolwani AJ.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1470-8. doi: 10.2215/CJN.10461013. Epub 2014 Mar 20.

12.

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD.

Am J Kidney Dis. 2013 May;61(5):649-72. doi: 10.1053/j.ajkd.2013.02.349. Epub 2013 Mar 15. Review.

PMID:
23499048
13.

The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study.

Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, DaSilva JR, Astor BC, Yevzlin AS, Humes HD.

Semin Dial. 2013 Sep-Oct;26(5):616-23. doi: 10.1111/sdi.12032. Epub 2012 Oct 29.

PMID:
23106607
14.

Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

Bauer SR, Salem C, Connor MJ Jr, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH.

Clin J Am Soc Nephrol. 2012 Mar;7(3):452-7. doi: 10.2215/CJN.10741011. Epub 2012 Jan 26.

15.

Solute clearance in CRRT: prescribed dose versus actual delivered dose.

Lyndon WD, Wille KM, Tolwani AJ.

Nephrol Dial Transplant. 2012 Mar;27(3):952-6. doi: 10.1093/ndt/gfr480. Epub 2011 Sep 5.

16.

Critical care nephrology: management of acid-base disorders with CRRT.

Cerdá J, Tolwani AJ, Warnock DG.

Kidney Int. 2012 Jul;82(1):9-18. doi: 10.1038/ki.2011.243. Epub 2011 Aug 3. Review.

17.

Anticoagulation for continuous renal replacement therapy.

Tolwani AJ, Wille KM.

Semin Dial. 2009 Mar-Apr;22(2):141-5. doi: 10.1111/j.1525-139X.2008.00545.x. Review.

PMID:
19426417
18.

Introduction. The clinical application of CRRT--current status.

Tolwani AJ, Palevsky PM.

Semin Dial. 2009 Mar-Apr;22(2):107. doi: 10.1111/j.1525-139X.2008.00557.x. No abstract available.

PMID:
19426411
19.

Outcomes of critically ill children requiring continuous renal replacement therapy.

Hayes LW, Oster RA, Tofil NM, Tolwani AJ.

J Crit Care. 2009 Sep;24(3):394-400. doi: 10.1016/j.jcrc.2008.12.017. Epub 2009 Mar 27.

PMID:
19327959
20.

The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts.

Pisoni R, Wille KM, Tolwani AJ.

Nephron Clin Pract. 2008;109(4):c188-91. doi: 10.1159/000142927. Epub 2008 Sep 18. Review.

PMID:
18802366
21.

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM.

J Am Soc Nephrol. 2008 Jun;19(6):1233-8. doi: 10.1681/ASN.2007111173. Epub 2008 Mar 12.

22.

Efficacy and safety of renal tubule cell therapy for acute renal failure.

Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD.

J Am Soc Nephrol. 2008 May;19(5):1034-40. doi: 10.1681/ASN.2007080895. Epub 2008 Feb 13.

23.

A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.

Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM.

Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87. Epub 2005 Nov 23.

24.

Sustained low-efficiency dialysis.

Tolwani AJ, Wheeler TS, Wille KM.

Contrib Nephrol. 2007;156:320-4. Review.

PMID:
17464142
25.

Vascular grafts for hemodialysis: types, sites and techniques.

Warnock DG, Tolwani AJ, Gallichio M, Allon M.

Contrib Nephrol. 2004;142:73-93. Review. No abstract available.

PMID:
14719387
26.

Simplified citrate anticoagulation for continuous renal replacement therapy.

Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG.

Kidney Int. 2001 Jul;60(1):370-4.

27.

Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimiri sciureus).

Tolwani RJ, Waggie KS, Green SL, Tolwani AJ, Lyons DM, Schatzberg AF.

J Med Primatol. 2000 Feb;29(1):42-5.

PMID:
10870674

Supplemental Content

Loading ...
Support Center